Acadia: Q3 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Acadia Pharmaceuticals Inc. (ACAD) on Thursday reported a loss of $65.2 million in its third quarter.
On a per-share basis, the San Diego-based company said it had a loss of 40 cents.
The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 43 cents per share.
The drugmaker posted revenue of $211.7 million in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $194.4 million.
Acadia shares have risen 44% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $22.99, a climb of 44% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACAD at https://www.zacks.com/ap/ACAD
